We are live on ! Find out more
CPV

Canaan Partners VII Portfolio holdings

AUM $32.3M
1-Year Est. Return 154.97%
This Fund
S&P 500
This Quarter Est. Return
-18%
1 Year Est. Return
+154.97%
3 Year Est. Return
-20.69%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$511M
AUM Growth
-$427M
Cap. Flow
-$263M
Cap. Flow %
-51.5%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$8.93M

Top Sells

Rank Stock Value
1
HAPN
Happen Inc
HAPN
+$272M

Sector Composition

Rank Sector Weight
1 Financials 87.83%
2 Communication Services 4.52%
3 Healthcare 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAPN
1
Happen Inc
HAPN
$2.12B
$449M 87.83%
6,086,735
-3,043,367
-33% -$272M
MRNS
2
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$28.6M 5.59%
615,350
– –
TLRA
3
DELISTED
Telaria, Inc.
TLRA
$23.1M 4.52%
7,944,522
– –
TBRA
4
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$10.5M 2.06%
+610,434
New +$8.93M

Similar funds

A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
MIGAR
Madison International Global Alpha Realty New York $25.9M AUM
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
TAM
Target Asset Management Singapore $21.4M AUM 66.83% 1-Year Est. Return

Canaan Partners VII's Q2 2015 Portfolio in Review

As of Q2 2015, Canaan Partners VII held 4 positions worth $511M, down 45% from $938M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners VII withdrew a net $263M in Q2 2015, reducing 1 holding. Its largest reduction was Happen Inc, cutting an estimated $272M.

By sector, the portfolio is most concentrated in Financials at 88% of assets, down from 96% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Canaan Partners VII opened a new position in Tobira Therapeutics, Inc. Common Stock worth $10.5M.

  • Canaan Partners VII's largest Q2 2015 buy was Tobira Therapeutics, Inc. Common Stock: 610,434 shares worth $10.5M.
  • Canaan Partners VII's biggest Q2 2015 reduction was Happen Inc, cutting an estimated $272M.
  • Canaan Partners VII's ten largest holdings make up 100% of its $511M portfolio in Q2 2015.
  • Canaan Partners VII opened 1 new position and closed 0 in Q2 2015.
  • Canaan Partners VII's portfolio value fell 45% quarter-over-quarter to $511M.

Based on Canaan Partners VII's 13F filing for Q2 2015, filed 13 Aug 2015.